Tempus, Pfizer partner for cancer drug development

Tempus, Pfizer partner for cancer drug development

Source: 
Pharmaceutical Business Review
snippet: 

Tempus has unveiled a multi-year strategic partnership with Pfizer for advancing the development of cancer drugs. 

Under the collaboration, both the companies will work together for further AI and machine learning-driven efforts in therapeutic development.